Literature DB >> 23179405

Mechanism of two novel human GJC3 missense mutations in causing non-syndromic hearing loss.

Ching-Chyuan Su1, Shuan-Yow Li, Yung-Chang Yen, Jhih-Hao Nian, Wei-Guang Liang, Jiann-Jou Yang.   

Abstract

Connexins (CXs), as a component of gap junction channel, are homologous four transmembrane-domain proteins, with numerous studies confirming their auditory functions. Among a cohort of patients having incurred non-syndromic hearing loss, we identified two novel missense mutations, p.R15G and p.L23H, in the GJC3 gene encoding CX30.2/CX31.3, as causally related to hearing loss in previous study. However, the functional alteration of CX30.2/CX31.3 caused by the mutant GJC3 gene remains unknown. In this study, we compared the intracellular distribution of mutant CX30.2/CX31.3 (p.R15G and p.L23H) with the wild-type (WT) protein in HeLa cells and the effect of the mutant protein had on those cells. Analytical results indicated that p.R15G and p.L23H mutant exhibited continuous staining along apposed cell membranes in the fluorescent localization assay, which is the same with the WT. Moreover, ATP release (hemichannel function) is less in HeLa cells carrying mutant GJC3 genes than those of WT expressing cells. We believe that although p.R15G and p.L23H mutants do not decrease the trafficking of CX proteins, mutations in GJC3 genes result in a loss of hemichannel function of CX30.2/CX31.3 protein, possibly causing hearing loss. Results of this study provide a novel molecular explanation for the role of GJC3 in hearing loss.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23179405     DOI: 10.1007/s12013-012-9481-8

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  6 in total

1.  Comparative analysis of the domestic cat genome reveals genetic signatures underlying feline biology and domestication.

Authors:  Michael J Montague; Gang Li; Barbara Gandolfi; Razib Khan; Bronwen L Aken; Steven M J Searle; Patrick Minx; LaDeana W Hillier; Daniel C Koboldt; Brian W Davis; Carlos A Driscoll; Christina S Barr; Kevin Blackistone; Javier Quilez; Belen Lorente-Galdos; Tomas Marques-Bonet; Can Alkan; Gregg W C Thomas; Matthew W Hahn; Marilyn Menotti-Raymond; Stephen J O'Brien; Richard K Wilson; Leslie A Lyons; William J Murphy; Wesley C Warren
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-10       Impact factor: 11.205

2.  Simvastatin Sodium Salt and Fluvastatin Interact with Human Gap Junction Gamma-3 Protein.

Authors:  Andrew Marsh; Katherine Casey-Green; Fay Probert; David Withall; Daniel A Mitchell; Suzanne J Dilly; Sean James; Wade Dimitri; Sweta R Ladwa; Paul C Taylor; Donald R J Singer
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

3.  Functional analysis of a nonsyndromic hearing loss-associated mutation in the transmembrane II domain of the GJC3 gene.

Authors:  Swee-Hee Wong; Wen-Hung Wang; Pin-Hua Chen; Shuan-Yow Li; Jiann-Jou Yang
Journal:  Int J Med Sci       Date:  2017-02-23       Impact factor: 3.738

4.  Epigenetic-smoking interaction reveals histologically heterogeneous effects of TRIM27 DNA methylation on overall survival among early-stage NSCLC patients.

Authors:  Xinyu Ji; Lijuan Lin; Sipeng Shen; Xuesi Dong; Chao Chen; Yi Li; Ying Zhu; Hui Huang; Jiajin Chen; Xin Chen; Liangmin Wei; Jieyu He; Weiwei Duan; Li Su; Yue Jiang; Juanjuan Fan; Jinxing Guan; Dongfang You; Andrea Shafer; Maria Moksnes Bjaanaes; Anna Karlsson; Maria Planck; Johan Staaf; Åslaug Helland; Manel Esteller; Yongyue Wei; Ruyang Zhang; Feng Chen; David C Christiani
Journal:  Mol Oncol       Date:  2020-09-03       Impact factor: 7.449

Review 5.  Connexin Mutations and Hereditary Diseases.

Authors:  Yue Qiu; Jianglin Zheng; Sen Chen; Yu Sun
Journal:  Int J Mol Sci       Date:  2022-04-12       Impact factor: 6.208

6.  Cryo-EM structure of human Cx31.3/GJC3 connexin hemichannel.

Authors:  Hyuk-Joon Lee; Hyeongseop Jeong; Jaekyung Hyun; Bumhan Ryu; Kunwoong Park; Hyun-Ho Lim; Jejoong Yoo; Jae-Sung Woo
Journal:  Sci Adv       Date:  2020-08-28       Impact factor: 14.136

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.